Acacia Research Corporation ACTG announced today that a
subsidiary has acquired patents relating to vascular device technology.
“Acacia and its subsidiaries continue to increase the number of patent
portfolios they control in the medical device and diagnostics sectors,”
commented Paul Ryan, CEO.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
